Sun Pharma falls after getting 8 observations from USFDA for Halol facility

16 Dec 2019 Evaluate

Sun Pharmaceutical Industries is currently trading at Rs. 433.80, down by 4.85 points or 1.11% from its previous closing of Rs. 438.65 on the BSE.

The scrip opened at Rs. 429.90 and has touched a high and low of Rs. 435.70 and Rs. 426.50 respectively. So far 191462 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 484.10 on 01-Apr-2019 and a 52 week low of Rs. 350.40 on 13-May-2019.

Last one week high and low of the scrip stood at Rs. 441.90 and Rs. 423.50 respectively. The current market cap of the company is Rs. 103723.25 crore.

The promoters holding in the company stood at 54.55%, while Institutions and Non-Institutions held 33.23% and 12.23% respectively.

United States Food and Drug Administration (USFDA) has conducted Good Manufacturing Practices (GMP) inspection of Sun Pharmaceutical Industries’ Halol facility in Gujarat from December 03 to 13, 2019. At the conclusion of the inspection, the agency issued a Form 483, with eight observations. The company is preparing the response to the observations, which will be submitted to the USFDA within 15 business days. The company is committed to addressing these observations promptly. The company remains committed to working closely with the USFDA and continues to enhance its GMP compliance on an ongoing basis.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Sun Pharma Inds. Share Price

1522.50 -22.75 (-1.47%)
15-May-2024 12:13 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1521.85
Dr. Reddys Lab 5935.05
Cipla 1405.00
Zydus Lifesciences 996.65
Lupin 1633.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.